Peters Malte

Track

Insider profile

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 56% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Peters Malte's trades of HOOKIPA Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
337.50
Quantity 92,695 +35.7%
Value US$3,243,451
Transaction date
Proposed sale
Price
202.55
Quantity 21,348
Value US$240,018
Transaction date
Proposed sale
Price
90.81
Quantity 24,491
Value US$3,102,020
Transaction date
Sale
Price
0.92
Quantity 29,176 -26.8%
Value US$26,842
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-09 2025-08-19
S Sale
92,695 +35.7%
337.50
US$3,243,451 		92,695 +35.7% 337.50 US$3,243,451
2025-08-27 2025-08-19
PrS Proposed sale
21,348
202.55
US$240,018 		21,348 202.55 US$240,018
2025-08-27 2025-08-19
PrS Proposed sale
24,491
90.81
US$3,102,020 		24,491 90.81 US$3,102,020
2025-07-23 2025-07-22
S Sale
29,176 -26.8%
0.92
US$26,842 		29,176 -26.8% 0.92 US$26,842